Savas Sencan, Ipek Saadet Edipoglu, Fatma Gul Ulku Demir, Gunay Yolcu, and Osman Hakan Gunduz. Korean J Pain 2019;32:301-6. https://doi.org/10.3344/kjp.2019.32.4.301

Savas Sencan, Gunay Yolcu, Serhad Bilim, Ozge Kenis-Coskun, and Osman Hakan Gunduz. Korean J Pain 2022;35:106-13. https://doi.org/10.3344/kjp.2022.35.1.106

Savas Sencan, Ipek Saadet Edipoglu, Alp Eren Celenlioglu, Gunay Yolcu, and Osman Hakan Gunduz. Korean J Pain 2020;33:226-33. https://doi.org/10.3344/kjp.2020.33.3.226

This study aimed to investigate and compare the effecs of face-to-face and internet-based Basic Body Awareness Therapy (BBAT), in patients with fibromyalgia (FM). FM-diagnosed patients were randomly allocated to one of three groups: face-to-face BBAT (F2F-BBAT), internet-based BBAT (I-BBAT), or a waiting list control group (CG). The F2F-BBAT group underwent individual 8-week BBAT sessions (2 sessions per week). The I-BBAT group received an equivalent dosage of BBAT via online video conferencing software. The primary outcome was the Fibromyalgia Impact Questionnaire Revised (FIQR). Secondary outcomes included the pressure pain threshold (PPT) via algometer, the PostureScreen Mobile^® (PSM) application, the Short Form McGill Pain Questionnaire (SF-MPQ), the Short Form 36 Health Survey (SF-36), and plasma fibrinogen and haptoglobin levels. A total of 41 patients completed the study. Both the F2F-BBAT (n = 14) and I-BBAT (n = 13) groups showed significant improvements in all outcome measures (p < 0.05) with no significant difference between them (p > 0.05). Conversely, the CG (n = 14) demonstrated no substantial improvements in the outcome measures (p > 0.05). Compared to the CG, both the F2F-BBAT and I-BBAT groups exhibited superior results in FIQR, PPT, PSM, SF-MPQ, and multiple SF-36 sub-parameters (p < 0.05). This study showed that BBAT delivered via internet-based telerehabilitation can have comparable effective results on clinical parameters with conventional face-to face BBAT in patients with FM. ClinicalTrials.gov: NCT04981132.

Background: Persistent spinal pain syndrome type‐2 (PSPS‐II) is a chronic condition that is characterized by severe pain and results in disability and a significant reduction in quality of life. Despite the wide range of interventional pain treatments that are applied, depending on the complexity of the etiology, epidural pulsed radiofrequency (EPRF) application has emerged as an approach that has gained popularity in recent years. Objective: The objective of this study is to examine the efficacy of EPRF in patients diagnosed with PSPS‐II. Methodology: In this prospectively designed study, patients with PSPS‐II who had not responded to conservative treatments and epidural steroid injections were subjected to fluoroscopy‐guided EPRF. Patients were evaluated with the Numeric Rating Scale (NRS) for pain severity and the Douleur Neuropathique‐4 (DN‐4) questionnaire for presence of neuropathic pain before the procedure and at one and three months after. Although the change in NRS score was established as the primary outcome measure, the change in the number of patients with neuropathic pain according to the DN‐4 was determined as the secondary outcome measure. Result: In the final analysis, data from 42 patients were evaluated. The analysis of the time‐dependent change in NRS revealed a statistically significant reduction in the scores for the first and third months, in comparison with the initial measurement. A significant decrease was observed in the number of patients diagnosed with neuropathic pain according to the DN‐4 questionnaire in the first month, in comparison with the baseline. However, no significant change was noted in the third month. Conclusion: The utilization of EPRF for the treatment of chronic radicular pain in the setting of PSPS‐II appears to be effective in the short term. Further studies are required to ascertain its long‐term effects. Trial Registration: ClinicalTrials.gov identifier: NCT06239857